表紙
市場調査レポート

免疫タンパク診断検査の世界市場:2015年〜2019年

Global Immunoprotein Diagnostic Testing Market 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 347452
出版日 ページ情報 英文 76 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.95円で換算しております。
Back to Top
免疫タンパク診断検査の世界市場:2015年〜2019年 Global Immunoprotein Diagnostic Testing Market 2015-2019
出版日: 2015年12月16日 ページ情報: 英文 76 Pages
概要

世界の免疫タンパク診断検査市場は、2014年〜2019年のCAGRで、7.34%の成長が見込まれています。

当レポートでは、世界の免疫タンパク診断検査市場について調査分析し、市場規模と成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

第1章 エグゼクティブサマリー

第2章 調査範囲

  • 市場概要
  • 主要ベンダー製品

第3章 市場調査手法

  • 調査手法
  • 経済指標

第4章 イントロダクション

  • 主な市場ハイライト

第5章 市場情勢

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第6章 市場区分:応用別

  • 応用別
  • 感染症
  • オンコロジー・内分泌検査
  • 自己免疫検査
  • アレルギー検査

第7章 地理区分

  • 南北アメリカ
  • 欧州・中東・アフリカ
  • アジア太平洋地域

第8章 市場促進要因

第9章 促進要因の影響

第10章 市場の課題

第11章 促進要因と課題の影響

第12章 市場動向

第13章 ベンダー情勢

  • 競合シナリオ
  • 市場シェア分析
  • その他の有力ベンダー

第14章 主要ベンダー分析

  • Beckman Coulter
  • DiaSorin
  • Roche Diagnostics
  • Siemens Healthcare
  • Thermo Fisher Scientific Inc

第15章 付録

  • 略語リスト

第16章 Technavioについて

図表

目次
Product Code: IRTNTR7797

Market outlook of the global immunoprotein diagnostic testing market

Immunoproteins are blood proteins that are used as analytes for different disease diagnostic assays like ELISA, CLIA, immunoturbidity assay, and RIA. The market for immunoprotein diagnostic testing is positively influenced by factors like the growing elderly population and the increased incidence and prevalence of chronic diseases. These factors foster the prospects for growth in this market and results in its healthy CAGR of more than 7% by 2019.

Growing focus on early disease diagnosis is the key driver for the growth of this market. Early diagnosis by immunoprotein diagnostic devices helps in disease screening and patient care management during a disease outbreak. Advantages like its ability to reduce the total healthcare expenditure and its ability to reduce the recovery time of patients are expected to impel market growth during the forecast period.

Application-based segmentation of the immunoprotein diagnostic testing market

  • Infectious disease testing
  • Oncology and endocrine testing
  • Autoimmune testing
  • Allergy testing

Technavio's market research analyst has estimated the infectious disease testing segment to be the largest market segment during the forecast period. The high incidence of infectious diseases is expected to result in the augmented need for novel diagnostic tests and new reagents. This recent increase in the incidence of infectious diseases is expected to result in the augmented demand for immunoprotein diagnostic tests as it helps in the early diagnosis of infectious ailments.

Geographical segmentation of the immunoprotein diagnostic testing market

  • APAC
  • EMEA
  • Americas

In this market research report, analysts estimate the Americas to dominate the market for immunoprotein diagnostic testing during the forecast period. In the Americas, the US is considered to be the largest revenue contributor due to the high prevalence of chronic and infectious diseases in this region. Factors like the rise in laboratory automation, shift to POC rapid diagnostic tests, and increased FDA approval for new products are envisaged to account for this region's high market share of nearly 46% by 2019.

Competitive landscape and key vendors

This market is characterized by the presence of intense competition between numerous large, medium, and small-sized manufacturers that provide different type of immunoprotein diagnostic products based on technologies like ELISA, RIA, and CLIA. These vendors form partnerships and provide premium-priced products to laboratories and patients so as to establish themselves in the market.

Leading vendors in this market are -

  • Beckman Coulter
  • Diasorin
  • Roche Diagnostics
  • Siemens Healthcare
  • Thermo Fisher Scientific

Other prominent vendors analyzed in this global market study are Abbott Laboratories, Affymetrix, Alere, bioMerieux, Bio-Rad Laboratories, Corgenix, Dako, Fujirebio Diagnostics, Merck Millipore, Meridian Bioscience, ORGENTEC Diagnostika, Sekisui Diagnostics, IBL International, ImmunoDX, Quidel Corporation, and Trinity Biotech.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2019?
  • What are the key factors driving the global immunoprotein diagnostic testing market?
  • What are the key market trends impacting the global immunoprotein diagnostic testing market?
  • What are the challenges to market growth?
  • Who are the key vendors in the global immunoprotein diagnostic testing market?
  • What are the market opportunities and threats faced by the vendors in the global immunoprotein diagnostic testing market?
  • Trending factors influencing the market shares of the EMEA, Americas, and APAC?
  • What are the key outcomes of the five forces analysis of the global immunoprotein diagnostic testing market?

Technavio also offers customization on reports based on specific client requirement.

Table of Contents

PART 01:Executive summary

  • Highlights

PART 02:Scope of the report

  • Market overview
  • Top-vendor offerings
  • Instruments
  • Assays
  • Instrument
  • Assays
  • Instruments
  • Assays
  • Instruments
  • Assays

PART 03:Market research methodology

  • Research methodology
  • Economic indicators

PART 04:Introduction

  • Key market highlights

PART 05:Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06:Market segmentation by application

  • Global immunoprotein diagnostic testing market by application 2015-2019
  • Infectious disease
  • Market size and forecast
  • Oncology and endocrinology testing
  • Market size and forecast
  • Autoimmune testing
  • Market size and forecast
  • Allergy testing
  • Market size and forecast

PART 07:Geographical segmentation

  • Immunoprotein diagnostic testing market in Americas
  • Market size and forecast
  • Immunoprotein diagnostic testing market in EMEA
  • Market size and forecast
  • Immunoprotein diagnostic testing market in APAC
  • Market size and forecast

PART 08:Market drivers

  • Rise in incidence of chronic and infectious diseases
  • Focus on early disease diagnosis
  • Increased usage of POC test kits

PART 09:Impact of drivers

PART 10:Market challenges

  • Limited detection capability and complexity
  • High cost of upgradation
  • Lack of skilled technicians

PART 11:Impact of drivers and challenges

PART 12:Market trends

  • Development in automation of assay system
  • Increasing usage of multiplex bead-based assays
  • Growing focus on emerging countries

PART 13:Vendor landscape

  • Competitive scenario
  • Key news
  • Mergers and acquisitions
  • Market share analysis 2014
  • Beckman Coulter
  • Diasorin
  • Roche Diagnostics
  • Siemens Healthcare
  • Thermo Fisher Scientific
  • Other prominent vendors

PART 14:Key vendor analysis

  • Beckman Coulter
    • Business overview
    • Business segmentation
    • Beckman Coulter in invitro diagnostic (IVD) sector
    • Recent developments
  • DiaSorin
    • Business overview
    • Business segmentation
    • Business segmentation by revenue 2013 and 2014
    • Geographical segmentation by revenue 2014
    • DiaSorin in in-vitro diagnostics
    • Recent developments
  • Roche Diagnostics
    • Business overview
    • Product segmentation
    • Business segmentation by revenue 2014
    • Business segmentation by revenue 2013 and 2014
    • Geographical segmentation by revenue 2014
    • Recent developments
  • Siemens Healthcare
    • Business overview
    • Business segmentation
    • Geographical segmentation by revenue 2014
    • Siemens Healthcare in diagnostics sector
    • Recent developments
  • Thermo Fisher Scientific Inc
    • Business overview
    • Business segmentation
    • Business segmentation by revenue 2014
    • Business segmentation by revenue 2013 and 2014
    • Geographical segmentation by revenue 2014
    • Recent developments

PART 15:Appendix

  • List of abbreviation

PART 16:Explore Technavio

List of Exhibits

  • Exhibit 01:Product offerings8
  • Exhibit 02:Global immunoprotein diagnostic testing market 2014-2019 ($ billions)
  • Exhibit 03:Five forces analysis
  • Exhibit 04:Segmentation of global immunoprotein diagnostic testing market by application
  • Exhibit 05:Segmentation of global immunoprotein diagnostic testing market by application 2014
  • Exhibit 06:Global infectious disease diagnostic testing market 2014-2019
  • Exhibit 07:Global oncology and endocrinologyendocrine immunoprotein diagnostic testing market 2014-2019
  • Exhibit 08:Global autoimmune immunoprotein diagnostic testing market 2014-2019
  • Exhibit 09:Global allergy immunoprotein diagnostic testing market 2014-2019
  • Exhibit 10:Segmentation of global immunoprotein diagnostic testing market by geography 2014
  • Exhibit 11:Segmentation of global immunoprotein diagnostic testing market by geography 2019
  • Exhibit 12:Segmentation of global infectious disease diagnostic testing market by geography 2014-2019
  • Exhibit 13:Immunoprotein diagnostic testing market in Americas 2014-2019 ($ billions)
  • Exhibit 14:Immunoprotein diagnostic testing market in EMEA 2014-2019 ($ billions)
  • Exhibit 15:Immunoprotein diagnostic testing market in APAC 2014-2019 ($ billions)
  • Exhibit 16:Impact of drivers
  • Exhibit 17:Impact of drivers and challenges
  • Exhibit 18:Key takeaways: Diasorin
  • Exhibit 19:Key takeaways: Roche Diagnostics
  • Exhibit 20:Key takeaways: Siemens Healthcare
  • Exhibit 21:Key takeaways: Thermo Fisher Scientific
  • Exhibit 22:Beckman Coulter: Business segmentation
  • Exhibit 23:DiaSorin: Business segmentation by revenue 2014
  • Exhibit 24:DiaSorin: Business segmentation by revenue 2013 and 2014
  • Exhibit 25:DiaSorin: Geographical segmentation by revenue 2014
  • Exhibit 26:Roche Diagnostics: Business segmentation by revenue 2014
  • Exhibit 27:Roche Diagnostics: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 28:Roche Diagnostics: Geographical segmentation by revenue 2014
  • Exhibit 29:Siemens Healthcare: Business segmentation
  • Exhibit 30:Siemens Healthcare: Geographical segmentation by revenue 2014
  • Exhibit 31:Thermo Fisher: Brands
  • Exhibit 32:Thermo Fisher: Business segmentation by revenue 2014
  • Exhibit 33:Thermo Fisher: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 34:Thermo Fisher: Geographical segmentation by revenue 2014
Back to Top